<!DOCTYPE html>
<html>
<head>
<title>12_1_MASTER_ALEXION_P03_T05_S02</title>
<meta name="viewport" content="user-scalable=no, width=device-width, initial-scale=1.0, maximum-scale=1.0"/>
<meta name="apple-mobile-web-app-capable" content="yes" />
<meta name="format-detection" content="telephone=no" />


<link href="../global/css/font.css" type="text/css" rel="stylesheet">
<link href="../global/css/global.css" type="text/css" rel="stylesheet">
<link href="css/main.css" type="text/css" rel="stylesheet">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head>
<body>
	<div id="container">
        <!--end elements-->
        <div id="main_container" class="bg_orange">
           	<div class="claim">
				<i18n id='claim'>
					NSAID CV relative risk profile<br>
					Estimated rate ratios with 95% confidence intervals
				</i18n>
			</div>
			<div class='sub_claim grey HelveticaNeueLTStd_bold'>
				<i18n id='v2_sub_claim'>
					Network meta-analysis of large-scale, randomised controlled<br>
					trials compared the relative CV risk of NSAIDs<sup>1</sup>			
				</i18n>
			</div>
			<div class='graph'>
				<div class='x_axis_txt'>
					<div>
						<i18n id='x_axis_txt1'>
							Myocardial<br>
							infarction
						</i18n>
					</div>
					<div>
						<i18n id='x_axis_txt2'>
							Stroke
						</i18n>
					</div>
					<div>
						<i18n id='x_axis_txt3'>
							Cardiovascular<br>
							death
						</i18n>
					</div>
					<div>
						<i18n id='x_axis_txt4'>
							Death
						</i18n>
					</div>
					<div>
						<i18n id='x_axis_txt5'>
							APTC
						</i18n>
					</div>
				</div>
				<div class='y_axis_txt'>
					<div class='napro'>
						<i18n id='y_axis_txt1'>
							Naproxen<br>
							worse
						</i18n>
					</div>				
					<div class='ipupro'>
						<i18n id='y_axis_txt2'>
							Ibuprofen<br>
							worse
						</i18n>
					</div>				
					<div class='napro'>
						<i18n id='y_axis_txt3'>
							Naproxen<br>
							worse
						</i18n>
					</div>				
					<div class='ipupro'>
						<i18n id='y_axis_txt4'>
							Diclofenac<br>
							worse
						</i18n>
					</div>				
					<div class='napro'>
						<i18n id='y_axis_txt5'>
							Naproxen<br>
							worse
						</i18n>
					</div>				
					<div class='ipupro'>
						<i18n id='y_axis_txt6'>
							Celecoxib<br>
							worse
						</i18n>
					</div>			
				</div>
			</div>
			<div class='graph_legend HelveticaLTStd_Roman legend1'>
				<i18n id='v2_legend1'>
					Estimates of rate ratios (95% credibility interval).<br>
					Primary outcome = myocardial infarction.
				</i18n>
			</div>
			<div class='graph_legend HelveticaLTStd_Roman legend2'>
				<i18n id='legend2'>
					Secondary outcome = stroke, death from CV disease; death from any cause.<br>
					APTC = Antiplatelet Trialists’ Collaboration composite outcome.
				</i18n>
			</div>

        </div>
        <!--End #main_container -->
		<!-- Ref -->
		<div class="ref_wrapper" id="S017_ref_all"></div>	
        <div id="scroll-wrapper" class="scroll_ref">
			<div id="scroller">	
                <h1 class="brown Helvetica_Round_Bold"><i18n id="S015_ref">References:</i18n></h1>
                
				<div class="ref HelveticaLTStd_Roman">
               		<span class="ref_number">1.</span>
                	<i18n id="S015_ref_txt0v4">Adapted from Trelle S et al. <i>BMJ</i> 2011; 342: c7086.</i18n>
                </div>	
				<!--end Ref-->
			</div>
            <div class="close"><span class="right"></span></div>
            <div class="arrow_ref"></div>
		</div>
		<!-- End ref -->
		
        <div class="info_wrapper" id="info_all"></div>	
		<div id="scroll-wrapper" class="scroll_info">
			<div id="scroller">	
				<h1 class="brown Helvetica_Round_Bold"><i18n id="S015_info">Study Design:</i18n></h1>
                
				<div class="ref HelveticaLTStd_Roman">
                    <i18n id="S015_info1">
						A network meta-analysis of cardiovascular safety of NSAIDs performed by Integrating all available direct and indirect evidence, including all large-scale, randomised trials comparing any NSAID with other NSAIDs or placebo 
						( 31 trials in 116, 429 patients with more than 115,000 patient years of follow-up were included). Patients were allocated to naproxen, ibuprofen, diclofenac, celecoxib, etoricoxib, rofecoxib, lumiracoxib or placebo.<sup>1</sup>
					</i18n>
				</div>  <!--end info-->
				
			</div>
            <div class="close"><span class="right"></span></div>
            <div class="arrow_info"></div>
		</div>
		<!-- End info -->		
        </div>	
</body>
	<script type="text/javascript" src="../global/js/config.js"></script>
    <script type='text/javascript' src='../framework/steal/steal.production.js?../framework,development'></script>
	
	<script src="resource:js/SystemBridge.js"></script>
	<script type="text/javascript" src="../global/js/havie.js"></script>
    <script type="text/javascript" src="../global/js/global.js"></script>
    <script type="text/javascript" src="../global/js/ref.js"></script>
    <script type="text/javascript" src="javascript/main.js"></script>	
</html>